title: Adrenal hormonal imbalance in acute intermittent porphyria patients: results of a case control study.
abstract: BACKGROUND
  Acute Intermittent Porphyria (AIP) is a rare disease that results from a deficiency of hydroxymethylbilane synthase, the third enzyme of the heme biosynthetic pathway. AIP carriers are at risk of presenting acute life-threatening neurovisceral attacks. The disease induces overproduction of heme precursors in the liver and long-lasting deregulation of metabolic networks. The clinical history of AIP suggests a strong endocrine influence, being neurovisceral attacks more common in women than in men and very rare before puberty. To asses the hypothesis that steroidogenesis may be modified in AIP patients with biochemically active disease, we undertook a comprehensive analysis of the urinary steroid metabolome.
  
  
  METHODS
  A case-control study was performed by collecting spot morning urine from 24 AIP patients and 24 healthy controls. Steroids in urine were quantified by liquid chromatography-tandem mass spectrometry. Parent steroids (17-hydroxyprogesterone; deoxycorticosterone; corticoesterone; 11-dehydrocorticosterone; cortisol and cortisone) and a large number of metabolites (N = 55) were investigated. Correlations between the different steroids analyzed and biomarkers of porphyria biochemical status (urinary heme precursors) were also evaluated. The Mann-Whitney U test and Spearman's correlation with a two tailed test were used for statistical analyses.
  
  
  RESULTS
  Forty-one steroids were found to be decreased in the urine of AIP patients (P < 0.05), the decrease being more significant for steroids with a high degree of hydroxylation. Remarkably, 13 cortisol metabolites presented lower concentrations among AIP patients (P < 0.01) whereas no significant differences were found in the main metabolites of cortisol precursors. Nine cortisol metabolites showed a significant negative correlation with heme precursors (p < 0.05). Ratios between the main metabolites of 17-hydroxyprogesterone and cortisol showed positive correlations with heme-precursors (correlation coefficient > 0.51, P < 0.01).
  
  
  CONCLUSIONS
  Comprehensive study of the urinary steroid metabolome showed that AIP patients present an imbalance in adrenal steroidogenesis, affecting the biosynthesis of cortisol and resulting in decreased out-put of cortisol and metabolites. This may result from alterations of central origin and/or may originate in specific decreased enzymatic activity in the adrenal gland. An imbalance in steroidogenesis may be related to the maintenance of an active disease state among AIP patients.
authors.affiliation: Bioanalysis Research Group, IMIM, Hospital del Mar Medical Research Institute, Doctor Aiguader 88, Barcelona 08003, Spain. opozo@imim.es.
authors.forename: Oscar J
authors.initials: OJ
authors.lastname: Pozo
authors.forename: Josep
authors.initials: J
authors.lastname: Marcos
authors.forename: Andreu
authors.initials: A
authors.lastname: Fabregat
authors.forename: Rosa
authors.initials: R
authors.lastname: Ventura
authors.forename: Gregori
authors.initials: G
authors.lastname: Casals
authors.forename: Paula
authors.initials: P
authors.lastname: Aguilera
authors.forename: Jordi
authors.initials: J
authors.lastname: Segura
authors.forename: Jordi
authors.initials: J
authors.lastname: To-Figueras
mesh_terms: D000311:Adrenal Glands / Q000378:metabolism*; D000328:Adult; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017118:Porphyria, Acute Intermittent / Q000652:urine*; D013256:Steroids / Q000652:urine*; D055815:Young Adult
chemical_list: D013256:Steroids
references.citation: Medicine (Baltimore). 1992 Jan;71(1):1-13
references.pmid: 1549056
references.citation: J Steroid Biochem Mol Biol. 2013 Nov;138:334-47
references.pmid: 23916492
references.citation: Acta Obstet Gynecol Scand. 2012 Dec;91(12):1445-52
references.pmid: 22924787
references.citation: J Exp Med. 1972 Nov 1;136(5):1043-53
references.pmid: 4263649
references.citation: J Clin Pathol. 2014 Jan;67(1):60-5
references.pmid: 23908454
references.citation: J Inherit Metab Dis. 2013 Sep;36(5):849-57
references.pmid: 23114748
references.citation: Clin Nephrol. 2008 May;69(5):339-46
references.pmid: 18538096
references.citation: Clin Chem. 1989 Dec;35(12):2281-4
references.pmid: 2591044
references.citation: Eur J Clin Invest. 2013 Jul;43(7):727-39
references.pmid: 23650938
references.citation: Lancet. 2004 Feb 28;363(9410):705-6
references.pmid: 15001330
references.citation: J Exp Med. 1973 Oct 1;138(4):754-63
references.pmid: 4270345
references.citation: J Inherit Metab Dis. 2006 Aug;29(4):580-5
references.pmid: 16817012
references.citation: Lancet. 2010 Mar 13;375(9718):924-37
references.pmid: 20226990
references.citation: J Intern Med. 2009 Sep;266(3):277-85
references.pmid: 19570056
references.citation: Science. 1977 Aug 12;197(4304):659-60
references.pmid: 877578
references.citation: Medicine (Baltimore). 2005 Jan;84(1):48-60
references.pmid: 15643299
references.citation: Clin Biochem. 2013 Jun;46(9):819-24
references.pmid: 23499585
references.citation: Anal Chim Acta. 2014 Feb 17;812:92-104
references.pmid: 24491769
references.citation: Neurosci Biobehav Rev. 2010 Sep;35(1):97-103
references.pmid: 20026350
references.citation: Semin Liver Dis. 1998;18(1):43-52
references.pmid: 9516677
references.citation: Physiol Res. 2006;55 Suppl 2:S43-66
references.pmid: 17298222
references.citation: Ann Intern Med. 1999 Mar 16;130(6):461-70
references.pmid: 10075613
references.citation: Endocr Rev. 2011 Feb;32(1):81-151
references.pmid: 21051590
references.citation: Clin Chem. 2011 Nov;57(11):1514-23
references.pmid: 21937752
references.citation: N Engl J Med. 1984 Sep 6;311(10):643-5
references.pmid: 6433194